ํ๋ฃจ๋์ ๋ฉ๊ธ๋ฃจ๋ฏผ
**ํ๋ฃจ๋์ ๋ฉ๊ธ๋ฃจ๋ฏผ(Flunixin meglumine)**์ ๊ฐ๋ ฅํ ์์ ์ ์ฉ ๋น์คํ ๋ก์ด๋์ฑ ํญ์ผ์ฆ์ (NSAID)๋ก ์งํต, ํญ์ผ, ํด์ด ๋ชฉ์ ์ผ๋ก ๋๋ฆฌ ์ฌ์ฉ๋ฉ๋๋ค. * **์ฃผ์ ์ฉ๋**: ๋ฏธ๊ตญ FDA์์ ๋ง, ์, ๋ผ์ง์ฉ์ผ๋ก ์น์ธ๋์์ต๋๋ค. ๋ง์์๋ **์ฐํต(colic)**๊ณผ ๊ด๋ จ๋ ๋ด์ฅํต์ ๋ํ ํ์ค ์งํต์ ๋ก ๊ฐ์ฃผ๋๋ฉฐ ๊ทผ๊ณจ๊ฒฉ๊ณ ์งํ์๋ ์ฌ์ฉ๋ฉ๋๋ค. ์์ ๋ผ์ง์์๋ ์ฃผ๋ก ํธํก๊ธฐ ์งํ ๋ฐ ๋ด๋ ์ํ์ฆ๊ณผ ๊ด๋ จ๋ ๋ฐ์ด์ ์กฐ์ ํ๋ ๋ฐ ์ฌ์ฉ๋ฉ๋๋ค. * **ํ๊ฐ ์ธ ์ฌ์ฉ**: ๊ณผ๊ฑฐ์๋ ์๋๋ฌผ(๊ฐ)์๋ ์ฌ์ฉ๋์์ผ๋, ํ์ฌ๋ ๋ ์์ ํ COX-2 ์ ํ์ NSAID(์: ์นดํ๋กํ, ๋ฉ๋ก์์บ)๋ก ๋์ฒด๋์์ต๋๋ค. ๊ณ ์์ด๋ NSAID ๋ ์ฑ์ ๋งค์ฐ ๋ฏผ๊ฐํ๋ฏ๋ก ์ผ๋ฐ์ ์ผ๋ก ๊ธ๊ธฐ์๋ฉ๋๋ค. * **์์ ์์ **: ํ๋ฃจ๋์ ์ ํจํ์ฑ ์ผํฌ ๋๋ฌผ์ ํ์ญํ์ ๊ฐ์ ํ๊ณ ๋ฐ์ถ๋๋ฌผ ๋ฐ ๋ง์ ๋ด์ฅํต์ ํ์ํ ํจ๊ณผ๋ฅผ ๋ณด์ด๋ ๊ฒ์ผ๋ก ์๋ ค์ ธ ์์ต๋๋ค. ๊ทธ๋ฌ๋ ์ฐํต ํ์์์ ๋ด๋ ์ํ์ฆ์ด๋ ์ฅ ๊ดด์ฌ์ ๊ด๋ จ๋ ํ๋ ๋ฐ ์ฌํ ์งํ๋ฅผ ์ํํ ์ ์์ต๋๋ค.
์์ฉ ๊ธฐ์ : Flunixin meglumine is a potent, non-selective inhibitor of the **cyclooxygenase (COX)** enzyme system. * **Mechanism**: Cell membrane phospholipids โ **Phospholipase A2** โ Arachidonic Acid โ **COX-1 / COX-2** โ Decreased production of **prostaglandins** and **thromboxanes**. * By inhibiting prostaglandin synthesis, it reduces inflammation, lowers body temperature (antipyretic), and provides significant analgesia. * Unlike some other NSAIDs, flunixin does not appreciably alter gastrointestinal motility in horses, making it highly suitable for colic management.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- As an analgesic ยท 1-2 mg/kg ยท IV ยท q24h
- As an analgesic (oral paste) ยท 1-4 mg/kg ยท PO ยท once daily
- As an analgesic ยท 1-2 mg/kg ยท IV ยท q24h
- As an analgesic (oral paste) ยท 1-4 mg/kg ยท PO ยท once daily
- General ยท 0.5-2 mg/kg ยท PO or IM ยท one time daily
- For labeled indications ยท 1.1-2.2 mg/kg (1-2 mL per 100 lbs. BW) ยท slow IV ยท once a day as a single dose or divided into two doses q12h ยท up to 3 days ยท Avoid rapid IV administration
- As an analgesic ยท 1.1-2.2 mg/kg ยท IV ยท q6-12 hours ยท Recommend 72 hour milk withdrawal at this dose rate
- As an analgesic for visceral pain ยท 0.25-1 mg/kg ยท IV ยท q12-24h
- Using combination product (Resflor Gold) ยท 40 mg/kg florfenicol/2.2 mg/kg flunixin (6 mL/100 lb. B.W.) ยท SC ยท once ยท Do not administer more than 10 mL at each site. Injection should be given only in the neck.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Known hypersensitivity to flunixin
- Cats (generally contraindicated due to availability of safer alternatives)
- Patients with preexisting GI ulcers (e.g., Equine Gastric Ulcer Syndrome - EGUS)
- Patients with significant renal, hepatic, or hematologic diseases
- Breeding bulls (lack of reproductive safety data)
- Use to ambulate cattle intended for slaughter
์ด์๋ฐ์
- Anaphylaxis (especially after rapid IV administration in horses and cattle)
- IM injection site reactions (localized swelling, induration, stiffness, sweating, and rarely clostridial myonecrosis)
- Gastrointestinal ulceration (oral and gastric ulcers, especially with prolonged use or high doses)
- Renal ischemia and nephrotoxicity (especially in dehydrated patients, dogs, and birds)
- Hematochezia and hematuria (reported in cattle treated > 3 days)
- Hypoproteinemia and hematologic abnormalities
์ฝ๋ฌผ ์ํธ์์ฉ
- Aspirin ยท May decrease plasma levels of flunixin and increase the likelihood of GI adverse effects (blood loss)
- Cyclosporine ยท May increase cyclosporine blood levels and increase the risk for nephrotoxicity
- Digoxin ยท May increase serum levels of digoxin; use with caution in severe cardiac failure
- Enrofloxacin ยท Increases AUC and elimination half-life of both flunixin and enrofloxacin in dogs
- Furosemide & other diuretics ยท May reduce the saluretic and diuretic effects of the diuretic
- Methotrexate ยท Serious toxicity has occurred with concomitant use; use together with extreme caution
- Nephrotoxic agents (e.g., aminoglycosides, amphotericin B) ยท Increased risk of synergistic nephrotoxicity
- Probenecid ยท May cause a significant increase in serum levels and half-life of flunixin
- Warfarin ยท May increase the risk for bleeding
๋ชจ๋ํฐ๋ง
- Analgesic, anti-inflammatory, and antipyretic efficacy
- Gastrointestinal effects (especially in dogs and horses)
- CBCs and occult blood in feces with chronic use in horses
- Renal parameters (BUN, Creatinine, USG) in susceptible species or dehydrated patients
๊ณผ์ฉ๋
Acute overdosage should be handled by using established protocols of emptying the gut (if oral ingestion and practical/possible) and treating the patient supportively. * **Gastric Ulceration**: A distinct possibility in horses that have received overdoses. Consider using prophylactic anti-ulcer medications (e.g., omeprazole) in overdosed horses. * **Renal Protection**: Ensure adequate hydration and monitor renal values closely.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.